Latest Boston Scientific Corporation Stories
Data Presented at the International Congress of Parkinson's Disease and Movement Disorders Demonstrate Superior Therapeutic Window for the Treatment of Parkinson's Disease NATICK, Mass., June
NATICK, Mass., June 4, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has initiated the RESPOND Post Market Registry to assess real world performance of the Lotus(TM) Valve System.
NATICK, Mass., June 3, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Wells Fargo 2014 Healthcare Conference on June 17 in Boston, MA. Dan
NATICK, Mass., June 3, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Goldman Sachs 35th Annual Global Healthcare Conference on June 10 in
EVOLVE Study Data Presented Today at EuroPCR 2014 Also Demonstrate Excellent Safety Profile NATICK, Mass., May 21, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) reported
Acquisition Expected to Strengthen Peripheral Interventions Business and Accelerate Growth in Peripheral Atherectomy and Thrombectomy Categories NATICK, Mass., May 15, 2014 /PRNewswire/
PARIS, May 15, 2014 /PRNewswire/ -- Boston Scientific Reinforces Its Commitment to Global Education and Innovation
PREDICt-RM Collaborative Study between Boston Scientific, American College of Cardiology and Yale University Highlights Improved Outcomes in ICD and CRT-D Patients followed with the LATITUDE(TM) System
Boston Scientific Shockless Implant Evaluation (SIMPLE) Study Results Presented at Heart Rhythm 2014, the Heart Rhythm Society's 35th Annual Scientific Sessions NATICK, Mass., May
Advanced Illumina(TM) 3D Programming Software Provides Highly Significant Pain Relief in Study Patients NATICK, Mass., May 8, 2014 /PRNewswire/ -- New retrospective data highlighting the Boston
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.